BRWJX
Price
$21.61
Change
-$1.41 (-6.13%)
Updated
Apr 3 closing price
Net Assets
391.91M
GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

BRWJX vs GFACX

Header iconBRWJX vs GFACX Comparison
Open Charts BRWJX vs GFACXBanner chart's image
MFS Blended Research Growth Eq I
Price$21.61
Change-$1.41 (-6.13%)
VolumeN/A
Net Assets391.91M
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
BRWJX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRWJX vs. GFACX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRWJX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. BRWJX (392M). BRWJX pays higher dividends than GFACX: BRWJX (0.39) vs GFACX (0.00). BRWJX was incepted earlier than GFACX: BRWJX (10 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than BRWJX (0.60). BRWJX is a more actively managed with annual turnover of: 48.00 vs. GFACX (25.00). BRWJX has a lower initial minimum investment than GFACX: BRWJX (0) vs GFACX (250). BRWJX annual gain was more profitable for investors over the last year : 4.75 vs. GFACX (-1.75). BRWJX return over 5 years is better than : 86.92 vs. GFACX (59.73).
BRWJXGFACXBRWJX / GFACX
Total Expense Ratio0.491.3636%
Annual Report Gross Expense Ratio0.601.3644%
Fund Existence10 years24 years-
Gain YTD-8.506-5.003170%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets392M280B0%
Annual Yield % from dividends0.390.00-
Returns for 1 year4.75-1.75-271%
Returns for 3 years25.290.634,006%
Returns for 5 years86.9259.73146%
Returns for 10 yearsN/A44.46-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences